Hydroxy-2-oxindole derivatives, which contain a quaternary stereogenic center at the 3-position, are a family of structurally diverse natural or nonnatural products with interesting biological activities. [1] The asymmetric synthesis of 3-hydroxy-2-oxindole derivatives, such as donaxaridine (1), [1b-c] (R)chimonamidine (2), [1d] CPC-1 (3), [1e] and (À)-flustraminol B (4) [1f] (Scheme 1, series I), has recently been intensely pursued, as these compounds exhibit a broad spectrum of biological activities and are promising potential drugs. Previously established methods [2] for the preparation of these derivatives mainly focused on the asymmetric hydroxylation of 3-substituted 2-oxindoles [3] and the nucleophilic addition to isatins, [4] employing compound A as a viable synthon (Scheme 1). The synthesis of related 3-hydroxy-2oxindole derivatives (5-7) of series II has attracted considerable interest for a long time because of their fascinating architectures and potential biological activities. For example, spirolactone 5 has shown potential cytotoxic activity. [1g-i] Spiroether 6 was reported to be a CB2 agonist and is thus a potential drug candidate for reducing neuropathic and bone pains, and for treating a host of diseases, including osteoarthritis, atherosclerosis, osteoporosis, and cancers. [1g] Hexahydrozaepino[2,3-b]indole 7, which bears a unique 5,7bicyclic framework, can be used as a tranquilizer for mammals and birds. [1h-i] However, to the best of our knowledge, no asymmetric protocol that affords this class of compounds has been presented to date.Compared with the traditional "single target" approach, the design of a common intermediate is the key in the total synthesis of different products through a divergent synthesis strategy, which has enabled the formation of a variety of target molecules without compromising efficiency. [5] As part of our ongoing research efforts toward the development and utilization of synthetic tools for the formation of quaternary stereogenic centers, [3b, 6] we were interested in designing a novel organocatalytic asymmetric reaction to achieve the divergent synthesis of 3-hydroxy-2-oxindole derivatives, including those in series I and II.Retrosynthetic analyses suggested that the synthetic route to intermediates A and B was reasonable. We deduced that compound C could be assembled as the common intermediate for the divergent synthesis of 3-hydroxy-2-oxindole derivatives of series I and II. We therefore focused on the asymmetric vinylogous aldol reaction of the carbonyl-activated allyl nucleophile D with isatin (Scheme 1).The Mukaiyama-type aldol reaction of silyl dienol ethers is the favored protocol to furnish vinylogous aldol adducts, but can suffer from low atom economy and efficiency. [7] In this context, a direct asymmetric approach for these reactions would be highly valuable. In recent years, cyclic 2-furanone derivatives have been used as versatile nucleophiles in direct vinylogous aldol reactions, as shown by the research groups of Zhang, [8a] Terada, [8b]...